학술논문
Safety, Tolerability, and Pharmacokinetics of a New Formulation of Nemiralisib Administered via a Dry Powder Inhaler to Healthy Individuals
Document Type
Short Communication
Author
Source
In Clinical Therapeutics June 2019 41(6):1214-1220
Subject
Language
ISSN
0149-2918